Navigation Links
HMS Holdings Corp. Announces Q3 2008 Results, 2008 Revised Guidance and Initial 2009 Guidance
Date:10/31/2008

l be available at http://www.hmsholdings.com for at least a 12-month period. Shareholders and interested investors are welcome to contact HMSY Investor Relations at 212-857-5986. Following the filing of the Form 10-Q, corporate executives will be available to respond to inquiries from shareholders and interested investors.

About HMS Holdings Corp.

HMS Holdings Corp. (Nasdaq: HMSY) is the nation's leader in coordination of benefits and program integrity services for government healthcare programs. The company's clients include health and human services programs in more than 40 states, 80 Medicaid managed care plans, the Centers for Medicare and Medicaid Services (CMS), and Veterans Administration facilities. HMS helps ensure that healthcare claims are paid correctly and by the responsible party. As a result of the company's services, government healthcare programs recover over $1 billion annually, and avoid billions of dollars more in erroneous payments.

This press release includes presentations of earnings before interest, taxes, depreciation and amortization (EBITDA) and adjusted EBITDA. Adjusted EBITDA represents EBITDA adjusted for share-based compensation expense. EBITDA is a measure commonly used by the capital markets to value enterprises. Interest, taxes, depreciation and amortization can vary significantly between companies due in part to differences in accounting policies, tax strategies, levels of indebtedness and interest rates. Excluding these items provides insight into the underlying results of operations and facilitates comparisons between HMSY and other companies. EBITDA is also a useful measure of the Company's ability to service debt and is one of the m
'/>"/>

SOURCE HMS Holdings Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2008 Fourth Quarter and Year End Earnings Webcast
2. XELR8 Holdings Announces Conference Call to Review Third Quarter Financial Results
3. China Pharma Holdings, Inc. to Initiate Clinical Trials For New Antibiotic Combination
4. HMS Holdings Corp. to Present at Oppenheimer 19th Annual Healthcare Conference
5. Lincare Holdings Inc. Announces Third Quarter and First Nine Months 2008 Financial Results
6. MINRAD International, Inc. Announces Change in Distribution Agreement with RxElite Holdings, Inc.
7. Z Trim Holdings, Inc. Releases Letter to Shareholders
8. Z Trim Holdings, Inc. Announces Private Placement Funding
9. MBF Healthcare Acquisition Corp. Amends Stock Purchase Agreement With Critical Homecare Solutions Holdings, Inc. to Extend Termination Date to October 31, 2008
10. Zimmer Holdings to Present at Thomas Weisel Partners Conference
11. HMS Holdings Corp. to Present at Thomas Weisel Partners 2008 Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...testicular cancer who were treated with cisplatin-...ncluding neurological side effects and Raynaud-lik...emotherapy, according to a new study published onl...ncer Institute . , Marianne Brydy, M.D., of the ...tal, in Bergen, Norway, and colleagues conducted a...
(Date:11/25/2009)...d was too short to draw definite conclusions, expe...Day News) -- In diabetic patients with blocked cor...in outcomes at one year whether patients undergo b...h researchers report. , Bypass surgery has been... coronary artery disease. However, less invasive a...
(Date:11/25/2009)...y neurological symptoms, study finds , ,...cal side effects are among the potential problems ...who were treated with cisplatin-based chemotherapy...,409 Norwegian men treated for unilateral testicul... follow-up survey conducted from 1998 to 2002. ,...
(Date:11/25/2009)...ntShownforthe4thStraightYear ,, WASHINGTON,No...iance-Georgia(LCA-GA)issuedthe 4thAnnualReportCard...ingmadeagainstthislethaldiseaseinthestateofGeorgia...nationalorganizationdedicatedexclusivelytopatients...gcancer. ,, (Logo: http://www.newscom.com/cgi-b...
(Date:11/25/2009)...er the skin kill tumor cells, study finds , ...cer vaccine delivered in a fingernail-size implant...eports. , The method uses polymer disks, 8.5 mi...specific antigens and implanted under the skin to ...Harvard University scientists who developed the im...
Breaking Medicine News(10 mins):Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Lung Cancer Alliance-Georgia Issues 4th Annual State-Specific Report Card on Lung Cancer 2
...ll and should not deter people from having the sur...althDay News) -- People who donate corneas are giv...g along a serious infection to the recipients, a n... in the February issue of the Archives of Ophthal...
.... 12 PSI, a leading provider of child,support enf...d today the,signing of a contract with the Ohio De...tinue delivering new hire reporting services for t...xtensions., Key responsibilities under the contra...
...b. 12 /PRNewswire/ - Over 5 million people in Nort...ng cause of hospitalization and for,the first time...ents want,to know - "How long do I have doctor?", ...d and diagnosed with heart failure. Scientists fol...
...Pa., Feb. 12 Herley Industries,Inc. (Nasdaq: HRL...ident,John M. Kelley, passed away after a lengthy ...Herley Industries, Inc. in 1998 as Director of,Inv...Technologies, and Executive Vice President before ...
... Fla., Feb. 12 The Generic Pharmaceutical,Associa...bers of its newly,elected Executive Committee and ...and CEO of Teva North America, to serve as its Cha...p 20,pharmaceutical companies in the world and is ...
...e International Experts to Educate Americans about...INNEAPOLIS, Feb. 12 Select Comfort Corporation,(N...and creator of the SLEEP,NUMBER(R) bed, has hand-p...an enhance their lives through better sleep,and a ...
Other Medicine News:Health News:Corneal Transplants Can Carry Infection Risk 2Health News:Corneal Transplants Can Carry Infection Risk 3Health News:Ohio Selects Policy Studies Inc. (PSI) to Continue Operating Its New Hire Reporting Program 2Health News:Precious Time - 'Scientists discover how long heart failure patients can expect to live' 2Health News:Precious Time - 'Scientists discover how long heart failure patients can expect to live' 3Health News:Herley Industries Announces the Passing of Its Former President 2Health News:GPhA Announces 2008-2009 Executive Committee; Teva North America's Bill Marth Elected as Chairman of the Board 2Health News:Select Comfort Creates Sleep Number Quality of Life Advisory Board to Improve Lives, Enhance Well-Being 2Health News:Select Comfort Creates Sleep Number Quality of Life Advisory Board to Improve Lives, Enhance Well-Being 3
(Date:11/25/2009)...irstCall/--AmericanScientificResourcesInc.(PinkShe...haveopenedaregionalmarketingandproductionmanagemen...urealocationabroad,providinganessentialgatewayfort...andsafetyproductsforchildrenandadultstobedistribut...ryinthestateofOhiowheretheywillalsobeabletodosubco...
(Date:11/25/2009)...5/PRNewswire/-- FromNovember16-18,Phonak,theleadin...dthesecondeditionoftheHearingCareforAdultsConferen...heconferencebroughttogetherleadingexpertsinagingan...nswhoworkeverydaywitholderpeoplewithhearinglossfor...researchandtrendsinhearingcareforolderpeople. ,...
(Date:11/25/2009)...swire/--AMPACFineChemicalsLLC(AFC),asubsidiaryofAm...daythatitreceivedtheEnvironmentalResponsibilityand...alSummit,sponsoredbytheCaliforniaManufacturersandT...talAssociation(IEA)andtheChemicalIndustryCouncilof...giousawardavailablefromallthreeorganizationsandgai...
Breaking Medicine Technology:American Scientific Resources Inc. Opens Shanghai Location 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2Dr Christopher Olivia Appointed to Foundation Radiology Group Board of Directors 52779 1Dr Christopher Olivia Appointed to Foundation Radiology Group Board of Directors 52779 2Dr Christopher Olivia Appointed to Foundation Radiology Group Board of Directors 52779 3Diplomat Specialty Pharmacy Receives Regional Good Neighbor Pharmacy Of The Year Award 52775 1Diplomat Specialty Pharmacy Receives Regional Good Neighbor Pharmacy Of The Year Award 52775 2PharmAthene Inc Announces 2419 3 Million Private Placement of Convertible Notes and Common Stock Warrants 52772 1PharmAthene Inc Announces 2419 3 Million Private Placement of Convertible Notes and Common Stock Warrants 52772 2PharmAthene Inc Announces 2419 3 Million Private Placement of Convertible Notes and Common Stock Warrants 52772 3PharmAthene Inc Announces 2419 3 Million Private Placement of Convertible Notes and Common Stock Warrants 52772 4
...he Treatment of Inflammatory ...Payment from Partner GlaxoSmithKline, MOUNTAIN VI...unced the initiation of a Phase I clinical trial o...e compound designed to specifically,target the CCR...ammatory,diseases such as rheumatoid arthritis. Wi...
...i Corporation (,Iomai,) in a, fully recommended sh...ai,s common stock representing a fully diluted e...llion (EUR 122 million). Acquisition to be, accomp...imately 41 percent of Iomai,s current shares outs...ly 1.7 million Intercell shares (representing appr...
Other Medicine Technology:ChemoCentryx Initiates Clinical Trial of CCR1 Inhibitor CCX354 2ChemoCentryx Initiates Clinical Trial of CCR1 Inhibitor CCX354 3ChemoCentryx Initiates Clinical Trial of CCR1 Inhibitor CCX354 4ChemoCentryx Initiates Clinical Trial of CCR1 Inhibitor CCX354 5Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 2Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 3Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 4Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 5Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 6Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 7Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 8Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 9Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 10Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 11
Basic modular VICTOR2 Multilabel Counter (3 technologies)
Manual VICTOR2 with fluorescence, fluorescence polarization and luminescence technologies
VICTOR2 V (5 technologies) with stackers and robotic loading
VICTOR2 multilabel counter with IR, high density TR-fluorometry, stacker and robot loading
Medicine Products: